Investor presentations: Tonix Pharmaceuticals Holding Corp (Tonix Pharma Press Release) - Apr 20, 2020 - "TNX-601 CR (Tianeptine Oxalate Controlled Release) Tablets; Proprietary new controlled release formulation for once-daily dosing; Plan to request pre-IND meeting with FDA in 2020; Plan for Phase 2 study in depression in 2021."
IND • New P2 trial • CNS Disorders • Depression • Mood Disorders • Psychiatry
|